Title |
Selective delivery of interleukine-1 receptor antagonist to inflamed joint by albumin fusion
|
---|---|
Published in |
BMC Biotechnology, September 2012
|
DOI | 10.1186/1472-6750-12-68 |
Pubmed ID | |
Authors |
Mengyuan Liu, Yi Huang, Lei Hu, Guoping Liu, Xueping Hu, Dongxu Liu, Xiaosong Yang |
Abstract |
Interleukin-1 receptor antagonist, a cytokine that is highly therapeutic to rheumatoid arthritis and several other inflammatory diseases, exhibits rapid blood clearance and poor retention time on the target in clinical application due to its small size and lack of specificity to target tissue. Albumin has been widely employed as macromolecular carrier for drug delivery purpose to extend the plasma half-life of therapeutic molecules and has been shown to selectively accumulate and to be metabolized in the inflamed joints of patients with rheumatoid arthritis. This suggests that genetic fusion of IL-1ra to albumin can probably overcome the drawbacks of in vivo application of IL-1ra. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Nepal | 1 | 33% |
United States | 1 | 33% |
Japan | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 2% |
Unknown | 44 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 14 | 31% |
Researcher | 8 | 18% |
Student > Doctoral Student | 4 | 9% |
Student > Bachelor | 3 | 7% |
Other | 2 | 4% |
Other | 5 | 11% |
Unknown | 9 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 10 | 22% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 13% |
Agricultural and Biological Sciences | 4 | 9% |
Medicine and Dentistry | 4 | 9% |
Immunology and Microbiology | 4 | 9% |
Other | 5 | 11% |
Unknown | 12 | 27% |